<SEC-HEADER>0001636050-17-000008.hdr.sgml : 20170214
<ACCEPTANCE-DATETIME>20170214163757
ACCESSION NUMBER:		0001636050-17-000008
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170214
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170214
DATE AS OF CHANGE:		20170214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axovant Sciences Ltd.
		CENTRAL INDEX KEY:			0001636050
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37418
		FILM NUMBER:		17609641

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Axovant Sciences, Inc.
		DATE OF NAME CHANGE:	20150324

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Roivant Neurosciences Ltd.
		DATE OF NAME CHANGE:	20150309
</SEC-HEADER>